Molecular Dynamics and Molecular Docking Studies on the Interaction between Four Tetrahydroxy Derivatives of Polyphenyls and Beta Amyloid

Document Type: Article


School of Chemistry, Damghan University, Damghan, Iran


Interactions of 3,3',4,4'-tetrahydroxybiphenyl (BPT) and three isomeric 3,3",4,4"-tetrahydroxyterphenyls (OTT, MTT, PTT) with Alzheimer’s amyloid-β peptide (Aβ) were studied by molecular dynamics simulation and molecular docking. Structural parameters such as Root-mean-square derivations (RMSD), radial distribution function (RDF), helix percentage and other physical parameters were obtained. These inhibitors have been evaluated and compared for their activity against aggregation of Aβ. The results showed that all four compounds successfully inhibit association of Aβ and reduce aggregation of protein. For the tetrahydroxyterphenyls efficacy varies with linker geometry: the ortho-position affords the most successful inhibition and the para-geometry the least perhaps due to differing abilities of these inhibitors to bind amyloid-β peptide. Of the four small inhibitors studied 3,3',4,4'-tetrahydroxybiphenyl (BPT) is the most effective inhibitor. Molecular docking studies have been done to confirm the simulation results. Investigation of binding site and free energy confirmed that the efficiency of interaction with Aβ depends on differing abilities of these inhibitors to bind amyloid-β peptide. Binding energy of BPT is more negative than the other and it significantly decreases for PTT. Self-aggregation of this inhibitor decreases in comparison with BPT; therefore Aβ aggregation in the presence of biphenyl form is higher than terphenyls.

Graphical Abstract

Molecular Dynamics and Molecular Docking Studies on the Interaction between Four Tetrahydroxy Derivatives of Polyphenyls and Beta Amyloid


Main Subjects

 [1] Hawkes CA, Ng V, McLaurin (2009) Small Molecule Inhibitors of A beta-Aggregation and Neurotoxicity. J. Drug Dev. Res 70: 111-124

[2] Re F, Airoldi C, Zona C, Masserini M, La Ferla B, Quattrocchi N, Nicotra F (2010) Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease. Curr. Med. Chem 17: 2990-3006

[3] Ferrão-Gonzales AD, Robbs BK, Moreau VH, Ferreira A, Juliano L, Valente AP, Almeida FCL, Silva JL, Foguel DJ (2005) Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. Biol. Chem 280: 34747-34754

[4] Howlett DR, Perry A, Godfrey F, Swatton JE, Jennings KH, Spitzfaden C, Wadsworth H, Wood SJ, Markwell RE (1999) Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans Biochem. J 340: 283-289

[5] Soto-Ortega DD, Murphy BP, Gonzalez-Velasquez FJ, Wilson KA, Xie F, Wang Q, Moss MA (2011) Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorg. Med. Chem 19: 2596-2602

[6] Moore SA, Huckerby TN, Gibson GL, Fullwood NJ, Turnbull S, Tabner BJ, El-Agnaf OM, Allsop D (2004) Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity. Biochemistry (2004) 43: 819-826

[7] Johnson SM, Connelly S, Wilson IA, Kelly JW (2008) Towards optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J Med Chem. 51: 6348-6358

[8] Novick PA, Lopes DH, Branson KM, Esteras-Chopo A, Graef IA, Bitan G, Pande VS (2012) Design of β-amyloid aggregation inhibitors from a predicted structural motif J Med Chem 55: 3002-3010

[9] Reinke AA, Gestwicki JE (2007) Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 70: 206-215

[10] Stevens CB, Hanna JM JR. Lammi RK (2013) Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-β aggregation inhibitors. Bioorg Med. Chem. Lett 23: 1703–1706

[11] Buchete NV, Tycko R, Hummer G (2005) Molecular dynamics simulations of Alzheimer's beta-amyloid protofilaments.J Mol Biol 353: 804-821

[12] Takeda T, Klimov DK (2009) Replica exchange simulations of the thermodynamics of Abeta fibril growth. Biophys J 96: 442-452

[13] Takeda T, Klimov DK (2009) Interpeptide interactions induce helix to strand structural transition in Abeta peptides. Proteins 77: 1-13

[14] Favrin G, Irback A, Mohanty S. (2004) Oligomerization of amyloid Aβ 16-22 peptides using hydrogen bonds and hydrophobicity forces. Biophys J 87: 3657-3664

[15] Klimov DK, Straub JE, Thirumalai D (2004) Aqueous urea solution destabilizes A β 16-22 oligomers. Proc Natl Acad Sci USA 101: 14760-14765

[16] Ajloo D, Sangian M, Ghadamghahi M, Evini M, Sabouri AA (2013) Effect of two imidazolium derivatives of ionic liquids on the structure and activity of adenosine deaminase. Int J Biol Macromol 55: 47-61

[17] Ajloo D, Ghalehaghababaie S, Mahmoodabadi N (2013) Molecular Dynamics Studies on the Denaturation of Polyalanine in the Presence of Guanidinium Chloride at Low Concentration. Phys Chem Res 1:152-165

 [18] Nandi S, Bagchi MC (2010) 3D-QSAR and molecular docking studies of 4-anilino quinazoline derivatives: a rational approach to anticancer drug design. Mol Divers 14:27–38

[19] Ye L, Wu J, Yang J, Chen W, Luo Y, Zhang Y (2015) Design, synthesis and molecular docking analysis of some novel 7-[(quinolin-6-yl)methyl] purines as potential c-Met inhibitors. Med Chem Res. 10.1007/s00044-015-1383-z

[20] Amiri M, Ajloo D (2014) QSAR and docking studies on the diaryltriazine analogs as HIV-1 reverse transcriptase inhibitors chem med res 23: 969-979

[21] Liu X, Chen X, Zhang L, Zhan P, Liu X (2015) 3D-QSAR and docking studies on piperidine-substituted diarylpyrimidine analogues as HIV-1 reverse transcriptase inhibitors. Med Chem Res. 10.1007/s00044-015-1381-1

[22] Eskici G, Gur M (2013) Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology. Plos one 8: e66178

[23] Hoover WG (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys Rev 31:1695-1697

[24] Nosé SA, (1984) A molecular dynamics method for simulations in the canonical esemble. Mol Phys 52:255-268

[25] Parrinello M, Rahman A (1980) Crystal Structure and Pair Potentials: A Molecular-Dynamics Study Phys Rev Lett 45:1196-1199

[26] van Der Spoel E, Lindahl B, Hess G, Groenhof AE, Mark HJ, Berendsen HJC (2005) GROMACS: fast flexible and free. J. Comput. Chem 26: 1701-1718

[27] Van Gunsteren WF, Billeter SR, Eising AA, Hunenberger PH, Kruger P, Mark AE, Scott WRP, Tironi IG (1996) Biomolecular Simulation: The GROMOS96 Manual and User Guide. Verlag der Fachvereine, Zürich, 1-1024

[28] Gerben SR, Lemlul JA, Brown AM, Bevan DR (2014) Synthesis of tetrahydroxybiphenyls and tetrahydroxyterphenyls and their evaluation as amyloid-b aggregation inhibitors. J. Biomol. Struct. Dyn 32: 1817-1832

[29] Berendsen HJC, Postma JPM, van Gunsteren WF, Hermans J (1981) Interaction Models for Water in Relation to Protein Hydration. In Intermolecular Forces; B. Pullman Ed Reidel: Dordecht Holland 331-342

[30] Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, Wishart DS (2003) VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 31:3316-3319